pentobarbital will minimize the extent or influence of diazepam buccal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Sturdy or average CYP3A4 inducers might boost price of diazepam elimination; therefore, efficacy of diazepam can be lessened.
pentobarbital will reduce the extent or effect of estrogens esterified by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
Reserve concomitant prescribing of these drugs in sufferers for whom other treatment method solutions are inadequate. Limit dosages and durations for the least required. Keep track of closely for signs of respiratory melancholy and sedation.
pentobarbital will lessen the extent or outcome of alosetron by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unidentified.
pentobarbital will reduce the level or effect of levoketoconazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Mysterious.
pentobarbital will decrease the extent or influence of solifenacin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will reduce the extent or result of netupitant/palonosetron by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Netupitant is mainly metabolized by CYP3A4; prevent use in sufferers who are chronically using a robust CYP3A4 inducer
pentobarbital will lower the extent or outcome of ramelteon by influencing hepatic enzyme CYP2C9/10 metabolism. Minimal/Importance Unknown.
pentobarbital will minimize the extent or outcome of budesonide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will minimize the extent or result of estradiol vaginal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will minimize the extent or effect of duvelisib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Coadministration with a strong CYP3A inducer decreases duvelisib place under the curve (AUC), which may lower duvelisib efficacy.
By clicking deliver, you accept that you have read more authorization to electronic mail the receiver with this info.
pentobarbital will lessen the extent or impact of lumacaftor/ivacaftor by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will minimize the extent or result of voriconazole by affecting hepatic enzyme CYP2C9/ten metabolism. Minor/Importance Unidentified.